Corcept Therapeutics Incorporated (CORT)
After hours:
| Previous close | 21.00 |
| Open | 21.13 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1000 |
| Day's range | 21.07 - 21.92 |
| 52-week range | 17.57 - 31.18 |
| Volume | |
| Avg. volume | 643,716 |
| Market cap | 2.453B |
| Beta (5Y monthly) | 0.68 |
| PE ratio (TTM) | 25.49 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Corcept Therapeutics (CORT) Alert: Shareholder Class Action In Part Survives Motion to Dismiss; Should Management be Held Accountable for Investors' Losses? Contact Johnson Fistel
SAN DIEGO, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential claims on behalf of Corcept Therapeutics, Inc. (NASDAQ: CORT) against certain of its officers and directors. Specifically, a class-action lawsuit pending in the Northern District of California issued an order denying in part the defendants' motion to dismiss in the pending securities class action against Corcept. According to the lawsuit, defendants throughout the Class Period made false and misleading st
- GlobeNewswire
SHAREHOLDER ALERT: Morris Kandinov Investigating MTCH, EHTH, CORT, and TDG; Shareholders are Encouraged to Contact the Firm
SAN DIEGO, Nov. 24, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Match Group, Inc., eHealth, Inc., Corcept Therapeutics, Inc., and TransDigm Group Incorporated. If you are a current owner of shares of any of these stocks, contact leo@moka.law or call (619) 708-3993. Match Group, Inc. (NASDAQ: MTCH) Accused of Misleading Investors On November 19, 2021, Judge Karen Gren Scholer of the United States District Court
- GlobeNewswire
Corcept Therapeutics to Present at Upcoming Investor Conferences
MENLO PARK, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the hormone cortisol, today announced that the company will present at the following investor conferences: Jefferies London Healthcare Conference Date: Tuesday, November 16, 2021Presentation Time: 5:00 pm GMTFormat: Firesi
